FA
ABBV icon

Faithward Advisors’s AbbVie ABBV Stock Holding History

Faithward Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,414
Closed -$1.69M – 263
2025
Q4 		$1.69M Buy
7,414
+3,367
+83% +$767K 0.25% 91
2025
Q3 		$937K Buy
4,047
+1,088
+37% +$222K 0.14% 122
2025
Q2 		$549K Buy
2,959
+350
+13% +$65K 0.09% 157
2025
Q1 		$547K Sell
2,609
-101
-4% -$19.6K 0.1% 146
2024
Q4 		$482K Sell
2,710
-65
-2% -$12K 0.08% 156
2024
Q3 		$548K Sell
2,775
-70
-2% -$13.1K 0.1% 156
2024
Q2 		$488K Buy
2,845
+70
+3% +$11.6K 0.09% 167
2024
Q1 		$505K Buy
+2,775
New +$478K 0.09% 152
2023
Q3 		– Sell
-2,030
Closed -$309K – 249
2023
Q2 		$309K Buy
2,030
+237
+13% +$34.8K 0.07% 137
2023
Q1 		$263K Buy
1,793
+380
+27% +$58.1K 0.06% 158
2022
Q4 		$228K Buy
+1,413
New +$217K 0.05% 136
2020
Q3 		– Sell
-3,234
Closed -$318K – 215
2020
Q2 		$318K Sell
3,234
-495
-13% -$43.6K 0.08% 102
2020
Q1 		$284K Sell
3,729
-1,109
-23% -$94.5K 0.08% 128
2019
Q4 		$428K Sell
4,838
-138,158
-97% -$11.5M 0.1% 105
2019
Q3 		$10.8M Buy
+142,996
New +$9.8M 2.4% 17

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Faithward Advisors's ABBV Position: Q1 2026 in Review

Faithward Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 7,414 shares — an estimated $1.69M sold.

Faithward Advisors first reported a position in ABBV in Q3 2019 and held it in 15 quarters. The position peaked at $10.8M in Q3 2019. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Faithward Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Faithward Advisors sold 7,414 AbbVie shares in Q1 2026, an estimated $1.69M.
  • Faithward Advisors first reported a position in AbbVie in Q3 2019 and held it in 15 quarters.
  • Faithward Advisors's AbbVie position peaked at $10.8M in Q3 2019.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.